期刊
IMMUNOLOGICAL REVIEWS
卷 225, 期 -, 页码 244-255出版社
WILEY
DOI: 10.1111/j.1600-065X.2008.00689.x
关键词
bacterial; lung; immunotherapies; phagocytosis; Fc receptors; antibodies
类别
资金
- NIH [PO1 AI056320, U54 AI057158]
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, P01AI056320] Funding Source: NIH RePORTER
Francisella tularensis can cause fatal respiratory tularemia in humans and animals and is increasingly being isolated in the United States and several European countries. The correlates of protective immunity against this intracellular bacterium are not known, and currently there are no licensed vaccines available for human use. Cell-mediated immunity has long been believed to be critical for protection, and the importance of humoral immunity is also now recognized. Furthermore, synergy between antibodies, T cell-derived cytokines, and phagocytes appears to be critical to achieve sterilizing immunity against F. tularensis. Thus, novel vaccine approaches should be designed to induce robust antibody and cell-mediated immune responses to this pathogen.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据